Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

53.57 +1.24 (+2.37%)
Streaming Delayed Price Updated: 3:22 PM EST, Jan 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CVS Health Corp

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
45 46 Next >
Constructing A Dividend Growth Stock Portfolio For Total Return
A common mistake that investors make regarding dividend portfolio construction is not having a well-thought-out plan. 
Via Talk Markets
Rite Aid Starts Selling Abortion Medication From Few Pharmacies: Report
Rite Aid Corp (NYSE: RAD) plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery. 
Via Benzinga
Is This Hot Dividend Stock a Buy for Growth Investors?
This health insurer is a world-class business. But does that make the stock a savvy buy? 
Via The Motley Fool
3 Dividend Stocks Trading Near Their 52-Week Lows
Income investors looking to buy on a pullback might be interested in these stocks. 
Via The Motley Fool
Time To Buy CVS Or Oak Street Health Stock On Potential Acquisition?
News of CVS Health potentially acquiring Oak Street Health for $10 billion broke this week and highlighted what could be another large acquisition in 2023. For Oak Street Health, the possibility of... 
Via Talk Markets
What 11 Analyst Ratings Have To Say About CVS Health
Via Benzinga
$100 Invested In CVS Health 20 Years Ago Would Be Worth This Much Today
Via Benzinga
2 Medical Stocks to Watch Heading Into 2023
The two healthcare companies easily outdid the S&P 500 this year. 
Via The Motley Fool
The Viral “Tripledemic” Opportunity
Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu... 
Via Talk Markets
Take Warren Buffett's Advice and Do This During the Bear Market
Buffett isn't concerned when stock prices fall. 
Via The Motley Fool
Why Disney, Boeing And CVS Are This Investor's Top Stocks For 2023
Sand Hill Global Advisors' Brenda Vingiello laid out her top stocks for 2023 Wednesday afternoon on CNBC's "Fast Money Halftime Report." Here's a look at her three best ideas for 
Via Benzinga
Can CVS Save Oak Street Health (OSH) Stock?
Oak Street Health (OSH) stock is a hot topic among traders on Tuesday following reports that CVS (CVS) intends to acquire the company. 
Via InvestorPlace
Stock Indexes Move Lower Ahead of Key Consumer Data, More Fed Speakers
(Tuesday Market Open) Investors remained subdued Tuesday morning after a reality check from Federal Reserve speakers yesterday and rising anticipation ahead of a key U.S. inflation measure. 
Via Benzinga
Stocks Sluggish After Fed Chair Comments
Wall Street is struggling for direction today, with all three major indexes trading on both sides of the aisle. 
Via Talk Markets
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. 
Via Benzinga
Coinbase Discloses Restructuring Plan Amid Macro Headwinds, Pfizer Rebuts Generic Version Of COVID-19 Oral Treatment In China, Microsoft Mulls $10B Investment In ChatGPT Owner: Today's Top Stories
Benzinga Coinbase Bows Down To Macro Headwinds, To Let Go Of 950 Employees 
Via Benzinga
Oak Street Health Might Be Next On Radar As M&A Pick For CVS Health
Oak Street Health Inc (NYSE: OSH) shares are trading higher as CVS Health Corp (NYSE: CVS) is reportedly exploring an acquisition of primary care center operator. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday! 
Via InvestorPlace
4 Dividend Stocks You Can Trust In a Bear Market
Dividend stocks can offer excellent returns in bear markets. 
Via The Motley Fool
3 Reliable Dividend Stocks You Can Buy With $600
With products and services that many of us can't live without, these businesses are poised to deliver steadily rising dividend payouts. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Over $400M Robinhood Stock Linked To Sam Bankman-Fried, Dell Eyes Reducing Dependence On China, Walgreens Swings To Quarterly Loss: Top Stories Today
Benzinga 
Via Benzinga
Walgreens Boots Alliance Might Be First Pharmacy To Dispense Abortion Pills, Others To Follow
Via Benzinga
Why Cano Health's Shares Dropped 27.9% in December
The company, which operates senior-oriented primary care centers, is running low on cash. 
Via The Motley Fool
FDA Permits Retail Pharmacies To Distribute Abortion Pills, Expanding Access After Supreme Court Ruling
Via Benzinga
Are These 2 Dividend Stocks in Danger of Cutting Their Payouts?
These stocks have payout ratios of around 90%, suggesting that their dividend payments may not be sustainable. 
Via The Motley Fool
3 Outstanding Dividend Growth Stocks to Buy for 2023
Steadily growing dividend payments from these stocks could do wonders for your passive income portfolio down the road. 
Via The Motley Fool
3 Beaten Up Healthcare Stocks With Expected Annual Returns Up To 19.2%
3 stocks in the healthcare sector that have a trailing one-year total return of at least -10% or worse, but offer at least 10% total returns over the next five years. 
Via Talk Markets
2 Unstoppable Dividend Growth Stocks to Buy in 2023 and Beyond
Nothing is more reassuring to an income investor than a boost to the dividend. 
Via The Motley Fool
Novartis Settles Antitrust Cases Related To Generic Entry For Hypertension Drug
Novartis AG (NYSE: NVS) will pay $245 million to end antitrust litigation accusing the company of trying to delay the U.S. launch of generic versions of its Exforge, which treats hypertension to lower... 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.